A federal appeals court has lifted a ban on federal funding for embryonic stem cell research.
Amy Ritter, PhD
Advertisement
Amy Ritter was Scientific Editor, BioPharm International.
Articles by Amy Ritter, PhD
The IMS institute has released its report on the use of medicines in the United States during 2010.
The US patent laws are undergoing a major revision, the first large revision since the Patent Act of 1952.
Nearly 900 therapies for the treatment, diagnosis or prevention of cancer are currently in development, according to a report released by PhRMA.
The National Institutes of Health?s (NIH) definition of embryonic stem (ES) cells poses new challenges for investigators who seek federal research funding.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
2
AI and Human Collaboration Essential for Bio/pharma Innovation
3
Sustainability and Stability in Excipients
4
Centralizing AI Strategy, Ensuring Process Integrity, and Balancing Quick Wins with Long-Term Drug Design in Bio/pharma
5
